scholarly journals Salvage esophagectomy with pancreatectomy for local recurrence of thoracic esophageal cancer after definitive chemoradiotherapy: A case report

2018 ◽  
Vol 42 ◽  
pp. 85-89
Author(s):  
Noriyuki Nishiwaki ◽  
Yasuhiro Tsubosa ◽  
Masahiro Niihara
Keyword(s):  
Esophageal Cancer ◽  
Case Report ◽  
Local Recurrence ◽  
Definitive Chemoradiotherapy ◽  
Thoracic Esophageal Cancer ◽  
Salvage Esophagectomy

scholarly journals Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report

2021 ◽  
Vol 80 ◽  
pp. 105617
Author(s):  
Wataru Hirose ◽  
Yusuke Taniyama ◽  
Fumiyoshi Fujishima ◽  
Chiaki Sato ◽  
Michiaki Unno ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Photodynamic Therapy ◽  
Case Report ◽  
Definitive Chemoradiotherapy ◽  
Salvage Esophagectomy

scholarly journals Definitive Chemoradiotherapy and Salvage Esophagectomy for Esophageal Cancer Associated With Multiple Lung Metastases: A Case Report

2014 ◽  
Vol 99 (5) ◽  
pp. 640-644
Author(s):  
Yoshihiko Fujinaka ◽  
Masaru Morita ◽  
Takefumi Ohga ◽  
Yoshihiro Kakeji ◽  
Tokujiro Yano ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Case Report ◽  
Distant Metastasis ◽  
Multimodal Therapy ◽  
Lung Metastases ◽  
Salvage Surgery ◽  
Complete Response ◽  
Definitive Chemoradiotherapy ◽  
Node Metastases ◽  
Salvage Esophagectomy

Abstract The prognosis of esophageal cancer with distant metastasis is dismal. We report a 70-year-old man with esophageal cancer and multiple lung and lymph node metastases. Complete response was achieved following definitive chemoradiotherapy. Twenty-four months after the initial chemoradiotherapy, local recurrence was detected but there was no evidence of distant metastasis. Therefore, the patient underwent salvage esophagectomy. The surgery was well tolerated without any postoperative complications. The patient is still alive 48 months after the salvage surgery. Our experience suggests that salvage esophagectomy is an important component of multimodal therapy for the recurrence of esophageal cancer.

Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer

2009 ◽  
Vol 100 (6) ◽  
pp. 442-446 ◽  
Author(s):  
Hiroshi Miyata ◽  
Makoto Yamasaki ◽  
Shuji Takiguchi ◽  
Kiyokazu Nakajima ◽  
Yoshiyuki Fujiwara ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Definitive Chemoradiotherapy ◽  
Thoracic Esophageal Cancer ◽  
Salvage Esophagectomy

scholarly journals Salvage Hyperthermo-chemotherapy for Local Recurrence of Cervical Esophageal Cancer after Definitive Chemoradiotherapy: A Case Report

2009 ◽  
Vol 25 (2) ◽  
pp. 53-58 ◽  
Author(s):  
MASAHIKO SUGIYAMA ◽  
MASARU MORITA ◽  
KOJI ANDO ◽  
HIROSHI SAEKI ◽  
YASUNORI EMI ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Case Report ◽  
Local Recurrence ◽  
Cervical Esophageal Cancer ◽  
Definitive Chemoradiotherapy

scholarly journals Salvage Robotic-Assisted Thoracoscopic Esophagectomy after Definitive Chemoradiotherapy for Clinical T4b Esophageal Cancer: A Case Report

2021 ◽  
Author(s):  
Ryohei Sasamori ◽  
Satoru Motoyama ◽  
Yusuke Sato ◽  
Akiyuki Wakita ◽  
Yushi Nagaki ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Main Bronchus ◽  
Left Main Bronchus ◽  
Thoracoscopic Esophagectomy ◽  
Left Main ◽  
Robot Assisted ◽  
Definitive Chemoradiotherapy ◽  
Thoracic Esophageal Cancer ◽  
Robotic Assisted ◽  
Salvage Esophagectomy

Abstract BackgroundAlthough twenty years have passed since the start of robot-assisted thoracoscopic esophagectomy, salvage esophagectomy by robotic-assisted surgery has not yet been introduced by almost surgeons. Theoretically, robot-assisted thoracoscopic esophagectomy (RATE) increases operative precision and maneuverability within the narrow space of the mediastinum. However, surgeons have doubted that RATE is indicated for patients with tumor invasion of adjacent vital organs clinically (cT4b) or patients with scar tissue from definitive chemoradiotherapy. Herein, we report our case of salvage RATE for cT4b thoracic esophageal cancer which invaded to the left main bronchus before definitive chemoradiotherapy.Case presentationA man in his 60’s with middle thoracic esophageal cancer [cT4b (left main bronchus) N1 M0 cStage IIIC] received definitive chemoradiotherapy (fluorouracil and cisplatin, total radiation dose of 60 Gy). After the chemoradiotherapy, upper gastrointestinal endoscopy revealed a residual primary tumor, and we performed robotic-assisted thoracoscopic subtotal esophagectomy and gastric tube reconstruction via a retrosternal route with three-field lymphadenectomy. Although it was difficult to dissect the tumor from adjacent organs, especially in the left main bronchus and pericardium, due to the scarring after definitive chemoradiotherapy, R0 surgery was achieved. With RATE, the high-resolution three-dimensional images, stable surgical field and stable motion are considerable advantages for salvage esophagectomy for cT4b tumors. At present (30 months after surgery), the patient’s performance status is 0 and he is alive without a recurrence. ConclusionsRobot-assisted thoracoscopic esophagectomy provided considerable advantages for salvage esophagectomy after definitive chemoradiotherapy for a cT4b tumor.

scholarly journals A Case Report of Laparoscopic Abdominal Lymphadenectomy as Salvage Surgery for Lymph Node Recurrence following Definitive Chemoradiotherapy for Esophageal Cancer

2014 ◽  
Vol 75 (4) ◽  
pp. 934-940
Author(s):  
Keisuke KAWAMORITA ◽  
Masahiro NIIHARA ◽  
Masafumi IE ◽  
Yasuhiro TSUBOSA ◽  
Masanori TOKUNAGA ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Case Report ◽  
Lymph Node ◽  
Salvage Surgery ◽  
Definitive Chemoradiotherapy ◽  
Lymph Node Recurrence

PS01.236: MEDIASTINOSCOPIC SALVAGE ESOPHAGECTOMY FOR RECURRENT ESOPHAGEAL CANCER AFTER DEFINITIVE CHEMORADIOTHERAPY IN A PREVIOUSLY PNEUMONECTOMIZED PATIENT

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 116-117
Author(s):  
Tomoyuki Okumura ◽  
Yasuyuki Seto ◽  
Susumu Aikou ◽  
Makoto Moriyama ◽  
Shinich Sekine ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Tumor Recurrence ◽  
Conflicts Of Interest ◽  
Primary Lung Cancer ◽  
Esophageal Wall ◽  
Thoracic Esophagus ◽  
Definitive Chemoradiotherapy ◽  
Transhiatal Approach ◽  
Salvage Esophagectomy ◽  
Sealing Device

Abstract Background Mediastinoscopic esophagectomy is a minimally invasive surgery for thoracic esophageal cancer avoiding one-lung ventilation or transthoracic procedure. Methods We performed for the first time in the literature, salvage esophagectomy with combination of mediastinoscopic cervical approach and laparoscopic/mediastinoscopic transhiatal approach for recurrent thoracic esophageal squamous cell carcinoma (ESCC) after definitive chemoradiotherapy (dCRT) in a patient who had previously undergone a left pneumonectomy for primary lung cancer. Results A 66-year-old man was diagnosed as local recurrence of lower ESCC (cT3N0M0 cStage II) at 9 years after dCRT. His medical history included left-sided pneumonectomy for lung adenocarcinoma 9 years previously. Then the patient was diagnosed as lower thoracic ESCC (cT3N1M0 cStage III) at 2 months after pneumonectomy. He received dCRT consisting of CDDP/5-FU infusion and irradiation (60 Gy) and achieved complete response. No evidence of tumor recurrence was observed at endoscopic surveillance up until 6 years after dCRT. For this present surgery, a cervical wound was made and the intramediastinal procedure was performed under pneumomediastinum. After mobilization of upper/middle thoracic esophagus, the esophageal wall was safely separated from the remaining part and the stump of the left main bronchus. Dense adhesions between the esophagus and fibrotic tissue at the site of previous left mediastinal pleural resection was divided using a sealing device. In the abdomen, 5 ports were inserted to perform abdominal and transhiatal procedures under CO2 insufflation. After mobilization of the stomach, fibrotic scar tissue around the lower esophagus was divided using a sealing device and the peri-esophageal space dissected from cervical and transhiatal approach were connected to completely mobilize the thoracic esophagus. The esophagectomy was uneventfully carried out followed by reconstruction with gastric conduit via retrosternal rout. Pathological findings demonstrated a moderately differentiated ESCC (pT3-AD pN1 M0 pStage III), indicating that R0 resection was successfully performed. The patient has been closely observed as an outpatient and was alive and healthy at 3 months after the operation without tumor recurrence. Conclusion Mediastinoscopic esophagectomy is a safe and curative treatment strategy for esophageal cancer patients who had a previous pneumonectomy, even in salvage surgery for recurrent cancer after dCRT. Disclosure All authors have declared no conflicts of interest.

scholarly journals Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy

2018 ◽  
Vol 10 (3) ◽  
pp. 1554-1562 ◽  
Author(s):  
Yusuke Taniyama ◽  
Yusuke Taniyama ◽  
Tadashi Sakurai ◽  
Takahiro Heishi ◽  
Hiroshi Okamoto ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Definitive Chemoradiotherapy ◽  
Salvage Esophagectomy
Sign in / Sign up

Export Citation Format

Share Document